RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jiangsu Hengrui Pharmaceuticals Co Stock

Jiangsu Hengrui Pharmaceuticals Co Revenue 2025

Jiangsu Hengrui Pharmaceuticals Co Revenue

30.09 B CNY

Ticker

600276.SS

ISIN

CNE0000014W7

WKN

A0M4DV

In 2025, Jiangsu Hengrui Pharmaceuticals Co's sales reached 30.09 B CNY, a 10.18% difference from the 27.31 B CNY sales recorded in the previous year.

The Jiangsu Hengrui Pharmaceuticals Co Revenue history

YEARREVENUE (undefined CNY)GROSS MARGIN (%)
2030e56.9933,79
2029e51.1337,66
2028e45.0842,72
2027e39.4748,79
2026e34.0756,53
2025e30.0964,01
2024e27.3170,52
202322.8284,39
202221.2883,53
202125.9185,50
202027.7487,90
201923.2987,47
201817.4286,58
201713.8486,61
201611.0987,08
20159.3285,27
20147.4582,35
20136.281,32
20125.4483,94
20114.5581,27
20103.7482,32
20093.0381,21
20082.3981,65
20071.9881,68
20061.4478,98
20051.1878,88
20041.1573,45

Jiangsu Hengrui Pharmaceuticals Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Jiangsu Hengrui Pharmaceuticals Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Jiangsu Hengrui Pharmaceuticals Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Jiangsu Hengrui Pharmaceuticals Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Jiangsu Hengrui Pharmaceuticals Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Jiangsu Hengrui Pharmaceuticals Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Jiangsu Hengrui Pharmaceuticals Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Jiangsu Hengrui Pharmaceuticals Co’s growth potential.

Jiangsu Hengrui Pharmaceuticals Co Revenue, EBIT and net profit per share

DateJiangsu Hengrui Pharmaceuticals Co RevenueJiangsu Hengrui Pharmaceuticals Co EBITJiangsu Hengrui Pharmaceuticals Co Net Income
2030e56.99 B undefined0 undefined0 undefined
2029e51.13 B undefined20.38 B undefined0 undefined
2028e45.08 B undefined18.26 B undefined0 undefined
2027e39.47 B undefined14.34 B undefined0 undefined
2026e34.07 B undefined7.89 B undefined7.82 B undefined
2025e30.09 B undefined6.53 B undefined6.48 B undefined
2024e27.31 B undefined6.21 B undefined6.01 B undefined
202322.82 B undefined4.53 B undefined4.3 B undefined
202221.28 B undefined3.56 B undefined3.91 B undefined
202125.91 B undefined4.03 B undefined4.53 B undefined
202027.74 B undefined6.46 B undefined6.33 B undefined
201923.29 B undefined5.67 B undefined5.33 B undefined
201817.42 B undefined4.23 B undefined4.07 B undefined
201713.84 B undefined3.73 B undefined3.22 B undefined
201611.09 B undefined2.84 B undefined2.59 B undefined
20159.32 B undefined2.41 B undefined2.17 B undefined
20147.45 B undefined1.69 B undefined1.52 B undefined
20136.2 B undefined1.43 B undefined1.24 B undefined
20125.44 B undefined1.28 B undefined1.08 B undefined
20114.55 B undefined1.03 B undefined891 M undefined
20103.74 B undefined833 M undefined724 M undefined
20093.03 B undefined689 M undefined666 M undefined
20082.39 B undefined614 M undefined423 M undefined
20071.98 B undefined366 M undefined415 M undefined
20061.44 B undefined271 M undefined207 M undefined
20051.18 B undefined226 M undefined162 M undefined
20041.15 B undefined188 M undefined123 M undefined

Jiangsu Hengrui Pharmaceuticals Co stock margins

The Jiangsu Hengrui Pharmaceuticals Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Jiangsu Hengrui Pharmaceuticals Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Jiangsu Hengrui Pharmaceuticals Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Jiangsu Hengrui Pharmaceuticals Co's sales revenue. A higher gross margin percentage indicates that the Jiangsu Hengrui Pharmaceuticals Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Jiangsu Hengrui Pharmaceuticals Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Jiangsu Hengrui Pharmaceuticals Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Jiangsu Hengrui Pharmaceuticals Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Jiangsu Hengrui Pharmaceuticals Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Jiangsu Hengrui Pharmaceuticals Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Jiangsu Hengrui Pharmaceuticals Co Margin History

Jiangsu Hengrui Pharmaceuticals Co Gross marginJiangsu Hengrui Pharmaceuticals Co Profit marginJiangsu Hengrui Pharmaceuticals Co EBIT marginJiangsu Hengrui Pharmaceuticals Co Profit margin
2030e84.39 %0 %0 %
2029e84.39 %39.86 %0 %
2028e84.39 %40.52 %0 %
2027e84.39 %36.34 %0 %
2026e84.39 %23.15 %22.97 %
2025e84.39 %21.72 %21.54 %
2024e84.39 %22.74 %21.99 %
202384.39 %19.87 %18.85 %
202283.53 %16.72 %18.36 %
202185.5 %15.57 %17.49 %
202087.9 %23.3 %22.82 %
201987.47 %24.33 %22.88 %
201886.58 %24.27 %23.34 %
201786.61 %26.95 %23.25 %
201687.08 %25.62 %23.34 %
201585.27 %25.89 %23.31 %
201482.35 %22.68 %20.34 %
201381.32 %22.97 %19.96 %
201283.94 %23.59 %19.82 %
201181.27 %22.64 %19.58 %
201082.32 %22.25 %19.34 %
200981.21 %22.75 %21.99 %
200881.65 %25.66 %17.68 %
200781.68 %18.48 %20.95 %
200678.98 %18.86 %14.41 %
200578.88 %19.17 %13.74 %
200473.45 %16.42 %10.74 %

Jiangsu Hengrui Pharmaceuticals Co Aktienanalyse

What does Jiangsu Hengrui Pharmaceuticals Co do?

Jiangsu Hengrui Pharmaceuticals Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Jiangsu Hengrui Pharmaceuticals Co's Sales Figures

The sales figures of Jiangsu Hengrui Pharmaceuticals Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Jiangsu Hengrui Pharmaceuticals Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Jiangsu Hengrui Pharmaceuticals Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Jiangsu Hengrui Pharmaceuticals Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Jiangsu Hengrui Pharmaceuticals Co stock

How much revenue did Jiangsu Hengrui Pharmaceuticals Co generate this year?

Jiangsu Hengrui Pharmaceuticals Co has achieved a revenue of 30.09 B CNY this year.

How much was the turnover of the company Jiangsu Hengrui Pharmaceuticals Co compared to the previous year?

The revenue of Jiangsu Hengrui Pharmaceuticals Co has increased by 10.18% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Jiangsu Hengrui Pharmaceuticals Co?

The revenue of Jiangsu Hengrui Pharmaceuticals Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Jiangsu Hengrui Pharmaceuticals Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Jiangsu Hengrui Pharmaceuticals Co so important for investors?

The revenue of Jiangsu Hengrui Pharmaceuticals Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Jiangsu Hengrui Pharmaceuticals Co pay?

Over the past 12 months, Jiangsu Hengrui Pharmaceuticals Co paid a dividend of 0.16 CNY . This corresponds to a dividend yield of about 0.33 %. For the coming 12 months, Jiangsu Hengrui Pharmaceuticals Co is expected to pay a dividend of 0.17 CNY.

What is the dividend yield of Jiangsu Hengrui Pharmaceuticals Co?

The current dividend yield of Jiangsu Hengrui Pharmaceuticals Co is 0.33 %.

When does Jiangsu Hengrui Pharmaceuticals Co pay dividends?

Jiangsu Hengrui Pharmaceuticals Co pays a quarterly dividend. This is distributed in the months of July, August, July, August.

How secure is the dividend of Jiangsu Hengrui Pharmaceuticals Co?

Jiangsu Hengrui Pharmaceuticals Co paid dividends every year for the past 0 years.

What is the dividend of Jiangsu Hengrui Pharmaceuticals Co?

For the upcoming 12 months, dividends amounting to 0.17 CNY are expected. This corresponds to a dividend yield of 0.36 %.

In which sector is Jiangsu Hengrui Pharmaceuticals Co located?

Jiangsu Hengrui Pharmaceuticals Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jiangsu Hengrui Pharmaceuticals Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jiangsu Hengrui Pharmaceuticals Co from 7/12/2024 amounting to 0.2 CNY, you needed to have the stock in your portfolio before the ex-date on 7/12/2024.

When did Jiangsu Hengrui Pharmaceuticals Co pay the last dividend?

The last dividend was paid out on 7/12/2024.

What was the dividend of Jiangsu Hengrui Pharmaceuticals Co in the year 2024?

In the year 2024, Jiangsu Hengrui Pharmaceuticals Co distributed 0.16 CNY as dividends.

In which currency does Jiangsu Hengrui Pharmaceuticals Co pay out the dividend?

The dividends of Jiangsu Hengrui Pharmaceuticals Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Jiangsu Hengrui Pharmaceuticals Co

Our stock analysis for Jiangsu Hengrui Pharmaceuticals Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jiangsu Hengrui Pharmaceuticals Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.